F. Ong
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Breast Lesions and Carcinomas
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 2
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Job van der Palen (3 shared papers)Jan J. Jobsen (3 shared papers)Hanneke C. Kluin‐Nelemans (8 shared papers)J. Hermans (7 shared papers)E.M. Noordijk (6 shared papers)P. W. Wijermans (6 shared papers)J.H. Meerwaldt (1 shared paper)K. van Groningen (1 shared paper)
- Journals
- Radiotherapy and Oncology (3 papers)Blood (2 papers)Annals of Hematology (2 papers)British Journal of Haematology (1 paper)Stem Cell Research & Therapy (1 paper)
- Partner nations
- NetherlandsSingaporeNew Zealand
In The Last Decade
F. Ong
18 papers receiving 430 citations
Peers
Comparison fields: 5 of 57
- Pathology and Forensic Medicine 162
- Cancer Research 118
- Hematology 86
- Genetics 48
- Oncology 116
Countries citing papers authored by F. Ong
This map shows the geographic impact of F. Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ong more than expected).
Fields of papers citing papers by F. Ong
This network shows the impact of papers produced by F. Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ong. The network helps show where F. Ong may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Ong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 122 | |
| 2 | 2003 | 79 | |
| 3 | 2015 | 60 | |
| 4 | Bcl-2 protein expression is not related to short survival in multiple myeloma. | 1995 | 33 |
| 5 | 2023 | 29 | |
| 6 | 1997 | 28 | |
| 7 | 1996 | 15 | |
| 8 | 1995 | 14 | |
| 9 | 2024 | 13 | |
| 10 | 1995 | 12 | |
| 11 | 2009 | 9 | |
| 12 | 2025 | 8 | |
| 13 | 1997 | 7 | |
| 14 | 1997 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2024 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 0 |
About F. Ong
F. Ong is a scholar working on Oncology, Hematology, Molecular Biology, Pathology and Forensic Medicine and Radiation, having authored 19 papers that have together received 439 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Advanced Radiotherapy Techniques (4 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), Breast Lesions and Carcinomas (2 papers), HER2/EGFR in Cancer Research (2 papers), Multiple and Secondary Primary Cancers (2 papers) and Meat and Animal Product Quality (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (162 citations), Cancer Research (118 citations), Hematology (86 citations), Genetics (48 citations) and Oncology (116 citations). F. Ong has collaborated with scholars based in Netherlands, Singapore and New Zealand. Frequent co-authors include Job van der Palen, Jan J. Jobsen, Hanneke C. Kluin‐Nelemans, J. Hermans, E.M. Noordijk, P. W. Wijermans, J.H. Meerwaldt, K. van Groningen, Sietske A. Riemersma and Augustinus D. G. Krol. Their work appears in journals such as Radiotherapy and Oncology, Blood, Annals of Hematology, British Journal of Haematology and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.